Back to Top
Imalumab Biosimilar - Research Grade
$710.00 - $6,900.00
Imalumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
MIFï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P14174
Shipping Conditions
Blue ice
Background
Macrophage migration inhibitory factor (MIF) is a pleiotropic pro-inflammatory cytokine implicated in inflammation, autoimmunity, and tumor progression, making it a broad target in immunology research. This research-grade anti-MIF recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of imalumab, intended strictly for research use only (RUO). Built to demanding in vivo standards, the ultra-pure, low-endotoxin formulation ships in scalable milligram (mg) to gram (g) quantities to support high-throughput and heavy-usage laboratories. It serves cytokine neutralization and blocking assays, binding characterization, in vitro screening, control reagent use, and in vivo inflammation models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













